102 related articles for article (PubMed ID: 17391115)
1. The soluble forms of CD28, CD86 and CTLA-4 constitute possible immunological markers in patients with abdominal aortic aneurysm.
Sakthivel P; Shively V; Kakoulidou M; Pearce W; Lefvert AK
J Intern Med; 2007 Apr; 261(4):399-407. PubMed ID: 17391115
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma.
Wong CK; Lun SW; Ko FW; Ip WK; Hui DS; Lam CW
Clin Exp Immunol; 2005 Jul; 141(1):122-9. PubMed ID: 15958078
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of soluble CTLA-4, CD28, CD80 and CD86 costimulatory molecules reflect disease severity of acute asthma in children.
Ip WK; Wong CK; Leung TF; Lam CW
Pediatr Pulmonol; 2006 Jul; 41(7):674-82. PubMed ID: 16703581
[TBL] [Abstract][Full Text] [Related]
4. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
5. Elevation of plasma soluble T cell costimulatory molecules CTLA-4, CD28 and CD80 in children with allergic asthma.
Ip WK; Wong CK; Leung TF; Lam CW
Int Arch Allergy Immunol; 2005 May; 137(1):45-52. PubMed ID: 15785081
[TBL] [Abstract][Full Text] [Related]
6. Soluble costimulatory factors sCD28, sCD80, sCD86 and sCD152 in relation to other markers of immune activation in patients with myasthenia gravis.
Kakoulidou M; Wang X; Zhao X; Pirskanen R; Lefvert AK
J Neuroimmunol; 2007 Apr; 185(1-2):150-61. PubMed ID: 17346804
[TBL] [Abstract][Full Text] [Related]
7. Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation.
Saverino D; Brizzolara R; Simone R; Chiappori A; Milintenda-Floriani F; Pesce G; Bagnasco M
Clin Immunol; 2007 May; 123(2):190-8. PubMed ID: 17321799
[TBL] [Abstract][Full Text] [Related]
8. Aberrant production of soluble co-stimulatory molecules CTLA-4 and CD28 in patients with chronic hepatitis B.
Cao J; Zhang L; Huang S; Chen P; Zou L; Chen H; Xiang Y; Lai X; Ren G
Microb Pathog; 2011 Oct; 51(4):262-7. PubMed ID: 21736935
[TBL] [Abstract][Full Text] [Related]
9. Increased production of circulating soluble co-stimulatory molecules CTLA-4, CD28 and CD80 in patients with rheumatoid arthritis.
Cao J; Zou L; Luo P; Chen P; Zhang L
Int Immunopharmacol; 2012 Dec; 14(4):585-92. PubMed ID: 22917707
[TBL] [Abstract][Full Text] [Related]
10. Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients.
Hock BD; O'Donnell JL; Taylor K; Steinkasserer A; McKenzie JL; Rothwell AG; Summers KL
Tissue Antigens; 2006 Jan; 67(1):57-60. PubMed ID: 16451202
[TBL] [Abstract][Full Text] [Related]
11. Aminoterminal propeptide of type III procollagen and matrix metalloproteinases-2 and -9 failed to serve as serum markers for abdominal aortic aneurysm.
Eugster T; Huber A; Obeid T; Schwegler I; Gürke L; Stierli P
Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):378-82. PubMed ID: 15749038
[TBL] [Abstract][Full Text] [Related]
12. Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse.
Wang H; Wang K; Zhong X; Dai Y; Wu A; Li Y; Hu X
J Neuroimmunol; 2012 Feb; 243(1-2):52-5. PubMed ID: 22177277
[TBL] [Abstract][Full Text] [Related]
13. Cytokines and systemic biomarkers are related to the size of abdominal aortic aneurysms.
Flondell-Sité D; Lindblad B; Kölbel T; Gottsäter A
Cytokine; 2009 May; 46(2):211-5. PubMed ID: 19251434
[TBL] [Abstract][Full Text] [Related]
14. Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patients.
Hock BD; Patton WN; Budhia S; Mannari D; Roberts P; McKenzie JL
Leukemia; 2002 May; 16(5):865-73. PubMed ID: 11986949
[TBL] [Abstract][Full Text] [Related]
15. Haptoglobin phenotypes and plasma haptoglobin levels in patients with abdominal aortic aneurysm.
Pan JP; Cheng TM; Shih CC; Chiang SC; Chou SC; Mao SJ; Lai ST
J Vasc Surg; 2011 May; 53(5):1189-94. PubMed ID: 21296538
[TBL] [Abstract][Full Text] [Related]
16. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
17. Soluble CTLA-4 in sera of patients with bronchial asthma.
Shi HZ; Mo XY; Zhong XN
J Asthma; 2005 Mar; 42(2):133-9. PubMed ID: 15871446
[TBL] [Abstract][Full Text] [Related]
18. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163.
Møller HJ; Moestrup SK; Weis N; Wejse C; Nielsen H; Pedersen SS; Attermann J; Nexø E; Kronborg G
Crit Care Med; 2006 Oct; 34(10):2561-6. PubMed ID: 16915112
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD86 protein in serum samples of patients with asthma.
Shi HZ; Xie ZF; Deng JM; Chen YQ; Xiao CQ
Thorax; 2004 Oct; 59(10):870-5. PubMed ID: 15454653
[TBL] [Abstract][Full Text] [Related]
20. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
